A Phase 2, randomized, partially blinded, active-controlled study assessing the efficacy and safety of variable anticoagulation reversal using the REG1 system in patients with acute coronary syndromes: results of the RADAR trial - Povsic, TJ; Vavalle, JP; Aberle, LH (Eur Heart J, 2013)
::::::::::((VOLUME; SEITEN ODER DOI; AUTOR BITTE ERGÄNZEN)).